{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ALIMENTARY TRACT AND METABOLISM" , "@language" : "en" } ,        { "@value" : "Tr\u00E1vic\u00ED trakt a metabolismus" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A11",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Vitaminy" , "@language" : "cs" } ,        { "@value" : "VITAMINS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A11" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A11C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Vitamin A a D v\u010Detn\u011B jejich kombinac\u00ED" , "@language" : "cs" } ,        { "@value" : "VITAMIN  A  AND D, INCL. COMBINATIONS OF THE TWO" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A11C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A11CC",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Vitamin D a analogy" , "@language" : "cs" } ,        { "@value" : "Vitamin D and analogues" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A11CC" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/A11CC04",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/A11C" ,        "http://linked.opendata.cz/resource/ATC/A11CC" ,        "http://linked.opendata.cz/resource/ATC/A" ,        "http://linked.opendata.cz/resource/ATC/A11" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Calcitriol" , "@language" : "en" } ,        { "@value" : "Kalcitriol" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "A11CC04" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001577",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hypercalcemia" , "@language" : "en" } ,        { "@value" : "Hyperkalc\u00E9mie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001000",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug toxicity" , "@language" : "en" } ,        { "@value" : "L\u00E9ky - toxicita" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001922",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Malabsorp\u010Dn\u00ED syndromy" , "@language" : "cs" } ,        { "@value" : "Malabsorption syndromes" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0003148",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Calcitriol" , "@language" : "en" } ,        { "@value" : "Kalcitriol" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003163" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022811" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0472480" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000001000" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001922" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001577" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/OSTEOD-0-25-MCG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0003148" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "OSTEOD 0,25 MCG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A11CC04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014099" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014097" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014098" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014096" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014095" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014094" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003163",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "V\u00E1pn\u00EDkov\u00E9 kan\u00E1ly - agonist\u00E9" , "@language" : "cs" } ,        { "@value" : "Calcium channel agonists" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022811",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Vitaminy" , "@language" : "cs" } ,        { "@value" : "Vitamins" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0472480",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Bone density conservation agents" , "@language" : "en" } ,        { "@value" : "Inhibitory kostn\u00ED resorpce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014099",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "OSTEOD 0,25 MCG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A11CC04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VITAMINA, VITAGENA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC128231_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.25RG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "OsteoD je indikov\u00E1n pro l\u00E9\u010Dbu:  \n- diagnostikovan\u00E9 postmenopauz\u00E1ln\u00ED osteopor\u00F3zy  \n- ren\u00E1ln\u00ED osteodystrofie u pacient\u016F s chronick\u00FDm selh\u00E1n\u00EDm ledvin a p\u0159edev\u0161\u00EDm u t\u011Bch, kte\u0159\u00ED podstupuj\u00ED  \n  dialyza\u010Dn\u00ED program  \n- hypoparatyre\u00F3za po chirurgick\u00FDch z\u00E1kroc\u00EDch  \n- idiopatick\u00E9 hypoparatyre\u00F3zy  \n- pseudohypoparatyre\u00F3zy  \n- vitamin D dependentn\u00ED rachitis  \n- rachitis z nedostatku fosf\u00E1t\u016F, rezistentn\u00ED na vitamin D.  \n  P\u0159\u00EDpravek mohou u\u017E\u00EDvat d\u011Bti od 3 let a  dosp\u011Bl\u00ED.\n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 20X0.25RG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014097",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "OSTEOD 0,25 MCG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A11CC04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VITAMINA, VITAGENA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC128231_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.25RG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "OsteoD je indikov\u00E1n pro l\u00E9\u010Dbu:  \n- diagnostikovan\u00E9 postmenopauz\u00E1ln\u00ED osteopor\u00F3zy  \n- ren\u00E1ln\u00ED osteodystrofie u pacient\u016F s chronick\u00FDm selh\u00E1n\u00EDm ledvin a p\u0159edev\u0161\u00EDm u t\u011Bch, kte\u0159\u00ED podstupuj\u00ED  \n  dialyza\u010Dn\u00ED program  \n- hypoparatyre\u00F3za po chirurgick\u00FDch z\u00E1kroc\u00EDch  \n- idiopatick\u00E9 hypoparatyre\u00F3zy  \n- pseudohypoparatyre\u00F3zy  \n- vitamin D dependentn\u00ED rachitis  \n- rachitis z nedostatku fosf\u00E1t\u016F, rezistentn\u00ED na vitamin D.  \n  P\u0159\u00EDpravek mohou u\u017E\u00EDvat d\u011Bti od 3 let a  dosp\u011Bl\u00ED.\n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 100X0.25RG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014098",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "OSTEOD 0,25 MCG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A11CC04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VITAMINA, VITAGENA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC128231_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.25RG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "OsteoD je indikov\u00E1n pro l\u00E9\u010Dbu:  \n- diagnostikovan\u00E9 postmenopauz\u00E1ln\u00ED osteopor\u00F3zy  \n- ren\u00E1ln\u00ED osteodystrofie u pacient\u016F s chronick\u00FDm selh\u00E1n\u00EDm ledvin a p\u0159edev\u0161\u00EDm u t\u011Bch, kte\u0159\u00ED podstupuj\u00ED  \n  dialyza\u010Dn\u00ED program  \n- hypoparatyre\u00F3za po chirurgick\u00FDch z\u00E1kroc\u00EDch  \n- idiopatick\u00E9 hypoparatyre\u00F3zy  \n- pseudohypoparatyre\u00F3zy  \n- vitamin D dependentn\u00ED rachitis  \n- rachitis z nedostatku fosf\u00E1t\u016F, rezistentn\u00ED na vitamin D.  \n  P\u0159\u00EDpravek mohou u\u017E\u00EDvat d\u011Bti od 3 let a  dosp\u011Bl\u00ED.\n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 194.6799926757812 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 209.3300018310547 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 30X0.25RG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014096",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "OSTEOD 0,25 MCG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A11CC04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VITAMINA, VITAGENA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC128231_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.25RG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "OsteoD je indikov\u00E1n pro l\u00E9\u010Dbu:  \n- diagnostikovan\u00E9 postmenopauz\u00E1ln\u00ED osteopor\u00F3zy  \n- ren\u00E1ln\u00ED osteodystrofie u pacient\u016F s chronick\u00FDm selh\u00E1n\u00EDm ledvin a p\u0159edev\u0161\u00EDm u t\u011Bch, kte\u0159\u00ED podstupuj\u00ED  \n  dialyza\u010Dn\u00ED program  \n- hypoparatyre\u00F3za po chirurgick\u00FDch z\u00E1kroc\u00EDch  \n- idiopatick\u00E9 hypoparatyre\u00F3zy  \n- pseudohypoparatyre\u00F3zy  \n- vitamin D dependentn\u00ED rachitis  \n- rachitis z nedostatku fosf\u00E1t\u016F, rezistentn\u00ED na vitamin D.  \n  P\u0159\u00EDpravek mohou u\u017E\u00EDvat d\u011Bti od 3 let a  dosp\u011Bl\u00ED.\n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 100X0.25RG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014095",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "OSTEOD 0,25 MCG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A11CC04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VITAMINA, VITAGENA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC128231_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.25RG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "OsteoD je indikov\u00E1n pro l\u00E9\u010Dbu:  \n- diagnostikovan\u00E9 postmenopauz\u00E1ln\u00ED osteopor\u00F3zy  \n- ren\u00E1ln\u00ED osteodystrofie u pacient\u016F s chronick\u00FDm selh\u00E1n\u00EDm ledvin a p\u0159edev\u0161\u00EDm u t\u011Bch, kte\u0159\u00ED podstupuj\u00ED  \n  dialyza\u010Dn\u00ED program  \n- hypoparatyre\u00F3za po chirurgick\u00FDch z\u00E1kroc\u00EDch  \n- idiopatick\u00E9 hypoparatyre\u00F3zy  \n- pseudohypoparatyre\u00F3zy  \n- vitamin D dependentn\u00ED rachitis  \n- rachitis z nedostatku fosf\u00E1t\u016F, rezistentn\u00ED na vitamin D.  \n  P\u0159\u00EDpravek mohou u\u017E\u00EDvat d\u011Bti od 3 let a  dosp\u011Bl\u00ED.\n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 30X0.25RG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014094",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "OSTEOD 0,25 MCG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/A11CC04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VITAMINA, VITAGENA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC128231_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.25RG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "OsteoD je indikov\u00E1n pro l\u00E9\u010Dbu:  \n- diagnostikovan\u00E9 postmenopauz\u00E1ln\u00ED osteopor\u00F3zy  \n- ren\u00E1ln\u00ED osteodystrofie u pacient\u016F s chronick\u00FDm selh\u00E1n\u00EDm ledvin a p\u0159edev\u0161\u00EDm u t\u011Bch, kte\u0159\u00ED podstupuj\u00ED  \n  dialyza\u010Dn\u00ED program  \n- hypoparatyre\u00F3za po chirurgick\u00FDch z\u00E1kroc\u00EDch  \n- idiopatick\u00E9 hypoparatyre\u00F3zy  \n- pseudohypoparatyre\u00F3zy  \n- vitamin D dependentn\u00ED rachitis  \n- rachitis z nedostatku fosf\u00E1t\u016F, rezistentn\u00ED na vitamin D.  \n  P\u0159\u00EDpravek mohou u\u017E\u00EDvat d\u011Bti od 3 let a  dosp\u011Bl\u00ED.\n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 20X0.25RG" , "@language" : "cs" } ] }] }